Elanco Animal Health Incorporated (ELAN) Insider Trading Activity

NYSE$25.355+0.79 (3.22%)
Market Cap
$12.27B
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
87 of 849
Rank in Industry
2 of 48

ELAN Insider Trading Activity

ELAN Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$2,610,757
11
92
Sells
$100,050
1
8

Related Transactions

Kurzius Lawrence Erikdirector
2
$1.15M
0
$0
$1.15M
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTOR
2
$578,338
0
$0
$578,338
VanHimbergen Robert MEVP and CFO
2
$247,352
0
$0
$247,352
Herendeen Pauldirector
1
$236,850
0
$0
$236,850
Modi Rajeev A.SEE REMARKS
2
$195,924
0
$0
$195,924
Harrington Michael Jdirector
1
$109,100
0
$0
$109,100
O'Neill ShivGC AND CORP SEC
1
$94,273
0
$0
$94,273
Bettington Timothy JSEE REMARKS
0
$0
1
$100,050
$-100,050

About Elanco Animal Health Incorporated

Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear …

Insider Activity of Elanco Animal Health Incorporated

Over the last 12 months, insiders at Elanco Animal Health Incorporated have bought $2.61M and sold $100,050 worth of Elanco Animal Health Incorporated stock.

On average, over the past 5 years, insiders at Elanco Animal Health Incorporated have bought $1.92M and sold $100,050 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Kurzius Lawrence Erik (director) — $1.15M. Simmons Jeffrey N (PRESIDENT, CEO AND DIRECTOR) — $578,338. VanHimbergen Robert M (EVP and CFO) — $247,352.

The last purchase of 40,000 shares for transaction amount of $935,920 was made by Kurzius Lawrence Erik (director) on 2026‑08‑20.

List of Insider Buy and Sell Transactions, Elanco Animal Health Incorporated

2026-10-15SaleBettington Timothy JSEE REMARKS
4,350
0.0009%
$23.00
$100,050
-2.46%
2026-08-20PurchaseKurzius Lawrence Erikdirector
40,000
0.008%
$23.40
$935,920
-2.84%
2026-08-18PurchaseO'Neill ShivGC AND CORP SEC
3,998
0.0008%
$23.58
$94,273
-3.02%
2026-08-12PurchaseHarrington Michael Jdirector
5,000
0.001%
$21.82
$109,100
+3.68%
2026-08-07PurchaseVanHimbergen Robert MEVP and CFO
4,200
0.0009%
$23.08
$96,926
+3.62%
2026-08-07PurchaseHerendeen Pauldirector
10,000
0.0021%
$23.68
$236,850
+3.62%
2026-05-15PurchaseSimmons Jeffrey NPRESIDENT, CEO AND DIRECTOR
4,971
0.001%
$20.09
$99,843
+19.21%
2026-05-15PurchaseModi Rajeev A.SEE REMARKS
4,911
0.001%
$20.35
$99,939
+19.21%
2025-12-12PurchaseKurzius Lawrence Erikdirector
10,000
0.002%
$21.30
$213,000
+11.23%
2025-12-11PurchaseSimmons Jeffrey NPRESIDENT, CEO AND DIRECTOR
22,000
0.0045%
$21.75
$478,496
+11.33%
2025-12-11PurchaseVanHimbergen Robert MEVP and CFO
6,950
0.0014%
$21.64
$150,427
+11.33%
2025-12-11PurchaseModi Rajeev A.SEE REMARKS
4,500
0.0009%
$21.33
$95,985
+11.33%
2025-03-11PurchaseKurzius Lawrence Erikdirector
10,000
0.0021%
$10.20
$102,000
+84.56%
2025-03-07PurchaseKurzius Lawrence Erikdirector
10,000
0.002%
$10.90
$109,000
+65.53%
2025-03-05PurchaseHOOVER R DAVIDdirector
25,000
0.005%
$10.90
$272,558
+69.86%
2024-08-22PurchaseHarrington Michael Jdirector
3,500
0.0007%
$14.85
$51,974
-11.91%
2024-08-12PurchaseSimmons Jeffrey NPRESIDENT, CEO AND DIRECTOR
100,000
0.02%
$13.01
$1.3M
-1.68%
2024-05-21PurchaseDOYLE WILLIAM Fdirector
15,000
0.0031%
$16.98
$254,700
-23.41%
2024-03-08PurchaseHarrington Michael Jdirector
3,100
0.0006%
$16.29
$50,494
-17.75%
2024-03-08PurchaseDOYLE WILLIAM Fdirector
15,000
0.003%
$16.30
$244,500
-17.75%
Total: 84
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Kurzius Lawrence Erikdirector
188647
0.0378%
$4.64M50
+47.4%
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTOR
171971
0.0344%
$4.23M90
<0.0001%
Modi Rajeev A.SEE REMARKS
160812
0.0322%
$3.95M30
<0.0001%
VanHimbergen Robert MEVP and CFO
137516
0.0275%
$3.38M20
Harrington Michael Jdirector
131451
0.0263%
$3.23M70
<0.0001%
Herendeen Pauldirector
111687
0.0224%
$2.74M20
<0.0001%
O'Neill ShivGC AND CORP SEC
87832
0.0176%
$2.16M10
HOOVER R DAVIDdirector
210000
0.042%
$5.16M240
<0.0001%
DOYLE WILLIAM Fdirector
76330
0.0153%
$1.88M20
<0.0001%
BILBREY JOHN Pdirector
41722
0.0084%
$1.03M60
<0.0001%
Hicks Michael-BryantSee Remarks
33936
0.0068%
$833,807.5220
<0.0001%
Anand Kapila Kdirector
27467
0.0055%
$674,864.1930
<0.0001%
Kinard David SSee Remarks
22569
0.0045%
$554,520.3320
<0.0001%
LIN SARENA SSee Remarks
20000
0.004%
$491,400.0010
<0.0001%
GARCIA ART Adirector
16465
0.0033%
$404,545.0520
+12.26%
Schacht Aaron LSee Remarks
13924
0.0028%
$342,112.6820
<0.0001%
Cabral Ramiro MartinSee Remarks
12741
0.0026%
$313,046.3720
<0.0001%
YOUNG TODD S.See Remarks
5000
0.001%
$122,850.0020
+15.95%
Kochevar Deborah Turnerdirector
3783
0.0008%
$92,948.3110
<0.0001%
Urbanek David AlanSee Remarks
76
0%
$1,867.3230
<0.0001%
Meer James MChief Accounting Officer
225
0%
$5,528.2510
<0.0001%
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$1,279,728,023
131
10.76%
$3.05B
Elanco Animal Health Incorporated
(ELAN)
$25,613,591
65
-3.30%
$12.27B
$14,599,168
59
12.79%
$1.66B
$102,709,455
46
30.55%
$1.45B
$73,762,556
45
-9.99%
$2.17B

ELAN Institutional Investors: Active Positions

Increased Positions278+62.9%32M+5.59%
Decreased Positions191-43.21%64M-11.28%
New Positions119New9MNew
Sold Out Positions42Sold Out8MSold Out
Total Postitions529+19.68%539M-5.69%

ELAN Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Dodge & Cox$1.86M16.65%82.76M-135,395-0.16%2025-09-30
Fmr Llc$1.47M13.15%65.36M+473,983+0.73%2025-09-30
Primecap Management Co/Ca/$1.13M10.05%49.96M-2M-3.49%2025-09-30
Vanguard Group Inc$1.09M9.78%48.59M+759,623+1.59%2025-09-30
Blackrock, Inc.$1.04M9.29%46.18M+23M+100.15%2025-09-30
T. Rowe Price Investment Management, Inc.$709,606.006.34%31.51M+12M+61.14%2025-09-30
Dimensional Fund Advisors Lp$556,439.004.97%24.71M+2M+8.63%2025-09-30
Ubs Group Ag$370,863.003.31%16.47M+6M+56.74%2025-09-30
State Street Corp$343,335.003.07%15.25M+6M+67.04%2025-09-30
Black Creek Investment Management Inc.$281,105.002.51%12.48M-7M-35.16%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.